These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1197269)

  • 1. Skeletal lesions and calcium metabolism in early renal failure.
    Malluche HH; Ritz E; Hodgson M; Kutschera J; Krause G; Seiffert U; Gati A; Lange HP
    Proc Eur Dial Transplant Assoc; 1975; 11():443-50. PubMed ID: 1197269
    [No Abstract]   [Full Text] [Related]  

  • 2. Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Kidney Int Suppl; 1983 Dec; 16():S171-4. PubMed ID: 6588249
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of hormonal regulation of phosphorus and calcium metabolism in chronic renal failure].
    Heynen G; Rorive G; Gaspar S; Franchimont P
    J Urol Nephrol (Paris); 1976; 82(4-5):343-6. PubMed ID: 942631
    [No Abstract]   [Full Text] [Related]  

  • 5. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS; Slatopolsky E; Reiss E; Avioli LV
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disturbances of calcium and phosphate metabolism in chronic renal failure].
    Noiri E; Okuda T; Kurokawa K
    Nihon Rinsho; 1992 Jan; 50 Suppl():512-20. PubMed ID: 1578732
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone composition and parathyroid function in chronic renal failure.
    Tougaard L; Sorensen E; Christensen MS; Brochner-Mortensen J; Rodbro P; Sorensen AW
    Acta Med Scand; 1977; 202(1-2):33-8. PubMed ID: 899880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
    Iwasaki-Ishizuka Y; Yamato H; Nii-Kono T; Kurokawa K; Fukagawa M
    Nephrol Dial Transplant; 2005 Sep; 20(9):1904-11. PubMed ID: 15985520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alkaline phosphatase in patients with chronic renal insufficiency. Histochemical picture in the bone isoenzyme activity (author's transl)].
    Horn V; Vokrouhlická O; Stĕpán J; Erben J; Pacovský V
    Cas Lek Cesk; 1977 Sep; 116(38):1165-70. PubMed ID: 922783
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum calcium and total calcium load in kidney disease.
    Gupta A; Wang J; Norris K
    Nephrol News Issues; 2003 Nov; 17(12):68-70, 72-4, 76 passim. PubMed ID: 14640013
    [No Abstract]   [Full Text] [Related]  

  • 11. Alkaline phosphatase bone isoenzyme activity in serum in various degrees of micromorphometrically assessed renal osteopathy.
    Siede WH; Seiffert UB; Bundschuh F; Malluche HH; Schoeppe W
    Clin Nephrol; 1980 Jun; 13(6):277-81. PubMed ID: 7408246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
    Nishio S; Hayashi S; Yoshihara H; Kobayagawa H
    Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P; Hrubý M
    Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to K/DOQI bone metabolism guidelines.
    Smith DH; Johnson ES; Thorp ML; Yang X
    J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid acidosis in uraemia.
    Muldowney FP; Donohoe JF; Carroll DV; Powell D; Freaney R
    Q J Med; 1972 Jul; 41(163):321-42. PubMed ID: 5072056
    [No Abstract]   [Full Text] [Related]  

  • 17. Catabolism in uremia: the impact of metabolic acidosis.
    Franch HA; Mitch WE
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S78-81. PubMed ID: 11443773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a relationship between plasma immunoreactive calcitonin and bone disease in chronic renal failure.
    Kanis JA; Heynen G; Earnshaw M; Russell RG; Woods CG; Franchimont P; Gaspar S; Oliver D; Ledingham JG
    Adv Exp Med Biol; 1977; 81():571-9. PubMed ID: 899941
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
    Portale AA; Morris RC
    Miner Electrolyte Metab; 1991; 17(4):211-20. PubMed ID: 1813783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
    Kanis JA; Earnshaw M; Heynen G; Russell RG; Woods CG
    Calcif Tissue Res; 1977 May; 22 Suppl():147-53. PubMed ID: 912516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.